Abbott Laboratories (ABT) Change in Cash (2009 - 2026)

Abbott Laboratories' Change in Cash history runs 18 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.

• In Q1 2026, Change in Cash fell 58.58% year-over-year to -$1.7 billion; the TTM figure through Mar 2026 stood at $271.0 million (up 9.27% YoY), while the FY2025 annual figure was $906.0 million, up 25.83% from the prior year.
• Change in Cash came in at -$1.7 billion for Q1 2026 at Abbott Laboratories, down from $1.0 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.3 billion in Q2 2022 to a low of -$2.1 billion in Q1 2022.
• A 5-year average of -$176.2 million and a median of $187.0 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash sank 274.67% in 2022 and jumped 1643.1% in 2025, its largest moves.
• Abbott Laboratories' Change in Cash stood at $288.0 million in 2022, then plunged by 35.07% to $187.0 million in 2023, then slumped by 68.98% to $58.0 million in 2024, then surged by 1643.1% to $1.0 billion in 2025, then tumbled by 270.03% to -$1.7 billion in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$1.7 billion, $1.0 billion, and $560.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison